Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2019
Historique:
received: 23 11 2018
accepted: 14 03 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 18 12 2019
Statut: epublish

Résumé

Human immunodeficiency virus (HIV)-1 and hepatitis C virus (HCV) are major contributors to the global disease burden with many experts recognizing the requirement of an effective vaccine to bring a durable end to these viral epidemics. The most promising vaccine candidates that have advanced into pre-clinical models and the clinic to eliminate or provide protection against these chronic viruses are viral vectors [e.g., recombinant cytomegalovirus, Adenovirus, and modified vaccinia Ankara (MVA)]. This raises the question, is there a need to develop DNA vaccines against HIV-1 and HCV? Since the initial study from Wolff and colleagues which showed that DNA represents a vector that can be used to express transgenes durably

Identifiants

pubmed: 31001491
doi: 10.3389/fcimb.2019.00091
pmc: PMC6456646
doi:

Substances chimiques

Vaccines, DNA 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

91

Références

Clin Infect Dis. 2011 Aug 1;53(3):296-302
pubmed: 21765081
Curr Top Microbiol Immunol. 2012;354:157-79
pubmed: 21203884
J Clin Invest. 2012 Jan;122(1):359-67
pubmed: 22201684
PLoS Pathog. 2011 Sep;7(9):e1002243
pubmed: 21912520
Transfus Med Hemother. 2016 May;43(3):203-22
pubmed: 27403093
J Infect Dis. 2014 Nov 1;210(9):1508-16
pubmed: 24823625
Nat Immunol. 2009 May;10(5):524-30
pubmed: 19305395
Science. 2001 Mar 23;291(5512):2413-7
pubmed: 11264538
Lancet. 2018 Jul 21;392(10143):232-243
pubmed: 30047376
Sci Transl Med. 2017 Aug 9;9(402):
pubmed: 28794282
J Immunol. 2005 Jan 1;174(1):277-83
pubmed: 15611250
Front Immunol. 2018 Jul 09;9:1574
pubmed: 30038624
Virology. 2006 Jan 20;344(2):412-20
pubmed: 16226783
PLoS One. 2014 Jul 09;9(7):e101591
pubmed: 25007091
J Virol. 2015 Aug;89(15):7991-8002
pubmed: 26018154
Nature. 2012 Nov 15;491(7424):463-7
pubmed: 23075848
Immunol Rev. 2011 Jan;239(1):99-108
pubmed: 21198667
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
Vaccine. 1997 Jul;15(10):1049-56
pubmed: 9269046
Gene Ther. 2016 Jan;23(1):26-37
pubmed: 26262584
Lancet Infect Dis. 2016 Jul;16(7):797-808
pubmed: 26922272
JCI Insight. 2017 May 4;2(9):
pubmed: 28469084
J Virol. 2015 Jan;89(1):83-96
pubmed: 25320297
J Immunol. 2018 Oct 1;201(7):1984-1993
pubmed: 30127085
N Engl J Med. 2021 Sep 16;385(12):e35
pubmed: 34525286
Nat Rev Immunol. 2016 Feb;16(2):79-89
pubmed: 26688350
Gut. 2019 Aug;68(8):1493-1503
pubmed: 30487267
PLoS One. 2017 Jul 18;12(7):e0181382
pubmed: 28719652
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
Curr Opin Virol. 2016 Jun;18:50-6
pubmed: 27023283
Science. 2011 Oct 28;334(6055):475-80
pubmed: 21903775
Nat Immunol. 2013 May;14(5):509-13
pubmed: 23542740
Nature. 2016 Dec 8;540(7632):284-287
pubmed: 27841870
Biochem Biophys Res Commun. 1999 Aug 2;261(2):445-51
pubmed: 10425204
Hum Vaccin Immunother. 2014;10(8):2357-65
pubmed: 25424943
J Hepatol. 2014 Nov;61(1 Suppl):S34-44
pubmed: 25443345
J Exp Med. 2010 Mar 15;207(3):553-64
pubmed: 20156972
Expert Rev Vaccines. 2006 Dec;5(6):803-25
pubmed: 17184219
Nature. 2016 Aug 25;536(7617):474-8
pubmed: 27355570
AIDS. 2002 Nov 8;16(16):2137-43
pubmed: 12409734
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2540-9
pubmed: 24927525
Mol Ther. 2013 Sep;21(9):1796-805
pubmed: 23752314
J Infect Dis. 2015 Nov 1;212(9):1407-19
pubmed: 25883387
J Infect Dis. 1998 Jul;178(1):92-100
pubmed: 9652427
J Infect Dis. 2010 Feb 15;201(4):600-7
pubmed: 20078213
PLoS One. 2011;6(8):e21225
pubmed: 21857901
Gene Ther. 2015 Jul;22(7):528-35
pubmed: 25786869
Cell Rep. 2018 Oct 2;25(1):68-79.e4
pubmed: 30282039
J Virol. 2018 Mar 28;92(8):
pubmed: 29437963
J Infect Dis. 2018 Oct 20;218(11):1722-1729
pubmed: 29982508
Nat Rev Microbiol. 2015 Jul;13(7):414-25
pubmed: 26052661
Mol Ther. 2004 Mar;9(3):452-7
pubmed: 15006613
Nat Immunol. 2014 Apr;15(4):319-22
pubmed: 24646598
Gut. 2018 Apr;67(4):767-775
pubmed: 29331944
Gastroenterology. 2019 Jan;156(2):418-430
pubmed: 30268785
Vaccine. 2015 May 11;33(20):2347-53
pubmed: 25820067
J Immunol Res. 2015;2015:503978
pubmed: 25861656
Lancet. 2018 Feb 10;391(10120):552-562
pubmed: 29217376
Curr Opin Virol. 2017 Feb;22:44-50
pubmed: 27987416
PLoS Pathog. 2016 Jan 08;12(1):e1005315
pubmed: 26745376
J Virol. 2008 Feb;82(4):1827-37
pubmed: 18045940
Vaccine. 2016 Nov 4;34(46):5488-5494
pubmed: 27742218
Nat Immunol. 2018 Feb;19(2):173-182
pubmed: 29311694
Int J Cancer. 2018 Apr 1;142(7):1467-1479
pubmed: 29159802
Vaccine. 2001 Apr 6;19(20-22):2862-77
pubmed: 11282197
PLoS Pathog. 2007 Nov;3(11):e157
pubmed: 18052528
Vaccine. 2014 Jun 5;32(27):3409-16
pubmed: 24742491
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81
pubmed: 17428922
Sci Transl Med. 2014 Nov 5;6(261):261ra153
pubmed: 25378645
Acta Pharm Sin B. 2016 Jan;6(1):26-31
pubmed: 26904396
Genet Vaccines Ther. 2003 Sep 16;1(1):2
pubmed: 14606963
J Infect Dis. 1998 Oct;178(4):1008-18
pubmed: 9806028
Nat Commun. 2014 Oct 30;5:5317
pubmed: 25354725
Nat Med. 2016 Jun;22(6):614-23
pubmed: 27158907
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
Immunity. 2016 Oct 18;45(4):889-902
pubmed: 27692609
J Exp Med. 2017 Jun 5;214(6):1567-1580
pubmed: 28526759
Nat Immunol. 2018 Feb;19(2):183-191
pubmed: 29311695
Lancet. 2015 Nov 21;386(10008):2078-2088
pubmed: 26386540
J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):601-5
pubmed: 17325604
Sci Rep. 2016 Jun 30;6:29131
pubmed: 27358023
Clin Exp Vaccine Res. 2016 Jan;5(1):6-11
pubmed: 26866018
Vaccine. 2011 Oct 26;29(46):8417-28
pubmed: 21864626
Front Immunol. 2019 Jan 18;9:3175
pubmed: 30713538
Parasite Immunol. 2012 Dec;34(12):562-9
pubmed: 23171040
J Immunol. 2017 Mar 15;198(6):2233-2237
pubmed: 28159905
Sci Transl Med. 2017 Dec 13;9(420):
pubmed: 29237759
Pharm Res. 2000 Mar;17(3):306-13
pubmed: 10801219
Hepatology. 2014 Jun;59(6):2140-51
pubmed: 24425349
Lancet Infect Dis. 2012 May;12(5):408-14
pubmed: 22541630
Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257955
J Clin Invest. 2012 Dec;122(12):4606-20
pubmed: 23143305
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7037-42
pubmed: 22509047
PLoS One. 2016 May 25;11(5):e0156213
pubmed: 27224423

Auteurs

Zelalem A Mekonnen (ZA)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Branka Grubor-Bauk (B)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Makutiro G Masavuli (MG)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Ashish C Shrestha (AC)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Charani Ranasinghe (C)

Molecular Mucosal Vaccine Immunology Group, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.

Rowena A Bull (RA)

Viral Immunology Systems Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.

Andrew R Lloyd (AR)

Viral Immunology Systems Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.

Eric J Gowans (EJ)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Danushka K Wijesundara (DK)

Virology Laboratory, Basil Hetzel Institute for Translational Health Research, Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH